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Abstract
Background: Antimicrobial resistance (AMR) is of growing concern globally and AMR status in sub-Saharan Africa (SSA) is
undefined due to a lack of real-time data recording, surveillance and regulation. World Health Organization (WHO) Joint
External Evaluation (JEE) reports are voluntary, collaborative processes to assess country capacities and preparedness to
prevent, detect and rapidly respond to public health risks, including AMR. The data from SSA JEE reports were analysed to
gain an overview of how SSA is working towards AMR preparedness and where strengths and weaknesses lie.
Methods: SSA country JEE AMR preparedness scores were analysed. A cumulative mean of all the SSA country AMR
preparedness scores was calculated and compared to the overall mean SSA JEE score. AMR preparedness indicators were
analysed, and data were weighted by region.
Findings: The mean SSA AMR preparedness score was 53% less than the overall mean SSA JEE score. East Africa had the
highest percentage of countries reporting having AMR National Action Plans in place, as well as human and animal
pathogen AMR surveillance programmes. Southern Africa reported the highest percentage of countries with training
programmes and antimicrobial stewardship.
Conclusions: The low mean AMR preparedness score compared to overall JEE score, along with the majority of countries
lacking implemented National Action Plans, suggests that until now AMR has not been a priority for most SSA countries. By
identifying regional and One Health strengths, AMR preparedness can be fortified across SSA with a multisectoral approach.
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Key points identified
 ‘Infection Prevention and Control’ (specifically in a
clinical setting) was the strongest AMR category
across SSA
 ‘Antimicrobial Stewardship’ was the weakest
category across SSA
 Veterinary AMR surveillance and stewardship is less
established than in clinical settings across SSA, so a
multidisciplinary approach to improving these areas
is needed to achieve One Health
 East Africa reported the strongest AMR response,
thus lessons can be adapted from this region across
the continent
Introduction
The 68th session of the World Health Assembly in May
2015 [1] adopted the World Health Organization’s
(WHO) global action plan on antimicrobial resistance
(AMR), where AMR was included as a sustainable devel-
opment goal to facilitate worldwide action to tackle a
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serious growing issue threatening global health [2]. Ac-
curate data on AMR were unavailable worldwide and
the expectations were that data collection, surveillance,
and research on AMR would deliver quality data [3].
The five pillars of the WHO plan were to 1) improve
awareness 2) obtain knowledge through surveillance 3)
reduce the infection incidence 4) optimise antimicrobial
use and 5) develop an economic case for sustainable in-
vestment needs for new medicines, diagnostic tools, vac-
cines, and other distinct interventions [1].
Western countries took up the challenges of the WHO
action plan and several initiatives from Western Europe
and the USA were established [4, 5]. From the data avail-
able, the rising trend in antibiotic-resistant bacteria ap-
pears to be reflected globally, with the increasing presence
of methicillin-resistant Staphylococcus aureus (MRSA),
extended-spectrum β-lactamase-producing (ESBL) Entero-
bacteriaceae, carbapenemase-producing Enterobacteria-
ceae (CRE), multi-resistant Pseudomonas aeruginosa,
vancomycin-resistant enterococci, and multi-drug resist-
ant Acinetobacter baumannii [6].
In contrast to high income countries, there are numer-
ous additional challenges to implementing effective and
sustainable AMR surveillance programmes in low and
middle income countries such as those in Africa. These
range from a lack of infrastructural and institutional
capacities, lack of investment and human resources,
underutilisation of available data and scarce dissemin-
ation to regulatory bodies [5, 7]. Routine AMR surveil-
lance continues to be based on local hospital data, small
cohort studies in neonatal and adult wards, routine la-
boratory samples taken from patients with suspected in-
fection and health-care associated infections [8, 9].
Major data gaps remain on the issue of AMR in Africa
including the actual burden of AMR in the community,
hospital settings, animals and the environment, as well
as microbial acquisition of AMR, transmission patterns,
genotypic evolution of antimicrobial resistance mecha-
nisms, clonal spread and asymptomatic carriage.
At a global level, the realisation of the increasingly ser-
ious nature of AMR has led to the formation of several
initiatives to improve the surveillance and capture of
AMR data. The WHO has created a number of AMR sur-
veillance initiatives, including the tripartite database
WHONET [10], the Advisory Group on Integrated Sur-
veillance of Antimicrobial Resistance (AGISAR) and the
Global Antimicrobial Resistance Surveillance System
(GLASS) [11]. The WHO has identified a list of priority
AMR pathogens to help address this, as shown in Table 1,
taken from [12]. Amidst some controversy, tuberculosis
was not included, despite growing antimicrobial resistance
[5]. There is a need to strengthen the AMR evidence
based data through proactive global surveillance and re-
search and enhancing coordination and collaboration be-
tween African countries. This is the first step towards a
true global action plan to tackle AMR with a multidiscip-
linary approach.
The need for a One Health approach cannot be under-
stated. Whilst the global threat of AMR has repeatedly
been attributed to inappropriate use of antimicrobials in
human and animal husbandry, AMR in animals and
humans without previous exposure to antimicrobials has
been observed. This highlights the complex evolution and
transmission dynamics among people, domestic and wild
animals and the environment [13–16]. Avoiding the hori-
zontal transfer of AMR between these compartments is
vital, as it is estimated that up to 75% of human infectious
pathogens that have emerged or re-emerged are zoonotic
[17]. The magnitude of environmental reservoirs, such as
waste water, in which these pathogens might be
Table 1 List of WHO’s GLASS priority pathogens
WHO Priority Level Species Resistance pattern
Priority 1: Critical Acinetobacter baumannii Carbapenem-resistant
Pseudomonas aeruginosa Carbapenem-resistant
Enterobacteriaceae* Carbapenem-resistant, 3rd generation cephalosporin-resistant
Priority 2: High Enterococcus faecium Vancomycin-resistant
Staphylococcus aureus Methicillin-resistant, vancomycin intermediate and resistant
Helicobacter pylori Clarithromycin-resistant
Campylobacter Fluoroquinolone-resistant
Salmonella spp. Fluoroquinolone-resistant
Neisseria gonorrhoeae Third generation cephalosporin-resistant, fluoroquinolone-resistant
Priority 3: Medium Streptococcus pneumoniae Penicillin-non-susceptible
Haemophilus influenzae Ampicillin-resistant
Shigella spp. Fluoroquinolone-resistant
* Enterobacteriaceae include: Klebsiella pneumonia, Escherichia coli, Enterobacter spp., Serratia spp., Proteus spp., and Providencia spp., Morganella spp. Taken
from [12]
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harboured, plus the complications of climate change, ur-
banisation, anthropogenic activities, resource depletion
and antimicrobial residues in the ecosystem further in-
creases the danger of AMR transferral [18–20]. The im-
portance of AMR surveillance is beginning to gain
traction in Africa [9, 21, 22], although it is often difficult
to identify whether data is collated, let alone what trends
in prevalence exist. Implementing an effective antimicro-
bial stewardship programme poses a big challenge in real
world settings and legislative knowledge is often low
among physicians, pharmacists and veterinarians [13, 23].
Alongside surveillance databases and committees, the
need to identify country-specific preparedness for poten-
tial public health risks, including AMR, resulted in the
publication of Joint External Evaluations (JEEs) [24].
JEEs are voluntary, collaborative processes to assess
country capacities to prevent, detect and rapidly respond
to public health risks. The target for AMR preparedness
for countries is described as having ‘a functional system
in place for the national response to combat AMR with
a One Health approach’ [24]. Of the 50 SSA countries
counted (as defined by WHO regions), as of March
2020, 44 had completed a JEE (86%). Figure 1 depicts
the JEE completion status of the SSA countries.
JEE reports are broken down into four areas (‘prevent’,
‘detect’, ‘respond’ and ‘International Health Regulations
(IHR) related hazards and points of entry’), and 19 sub-
areas within these, one of which is ‘AMR’, which is fur-
ther broken down into four categories. To help to iden-
tify whether a country has certain AMR indicators, a
number of technical questions for each category are pro-
vided in the JEE for the country to answer, then scores
are calculated based on the presence or absence of these
indicators. A score of 1 denotes no capacity, 2 limited
capacity, 3 developed capacity, 4 demonstrated capacity
and 5 sustainable capacity.
Whilst tackling AMR can be broken down into many
areas, as described in the JEEs, it is only by looking at
the whole picture that effective gains can be made. JEE re-
ports are created for individual countries and their results
have thus far not been compared, to identify strengths and
weaknesses across SSA. By exploring the JEE reports in
more detail and comparing SSA countries and regions, it
was possible to generate an overview of how the continent
is working towards AMR preparedness. By breaking this
down into African regions (West, Central, East and South-
ern), strengths can be pinpointed and adapted by coun-
tries who may need assistance. The knowledge gained
from the JEE AMR preparedness score comparisons can
be used to inform future AMR policies.
Methods
In this report, we aimed to identify the overall AMR pre-
paredness across SSA using the scores from the JEE
reports, so that strengths and weaknesses could be iden-
tified. To do this we analysed the 44 completed JEE re-
ports from SSA countries, which were accessed between
6th November 2018 and 22nd March 2020 [25]. The
mean SSA AMR score and SSA overall JEE score were
calculated from all of the country mean AMR and JEE
scores. To identify the performance of ‘AMR’ compared
to other sub-areas across SSA countries, the mean SSA
scores for the sub-area ‘AMR’ (the mean score for each
category and each country) were compared to the mean
SSA scores for each of the other sub-areas. An overview
of how the data were analysed is outlined in Figure 2.
One way ANOVA analysis was conducted to identify
statistically significant differences (p < 0.05) between cat-
egories using GraphPad Prism 8.4.2.
The percentage of countries which fell into each score
category was also calculated. Information from the ac-
companying technical questions was extracted and ana-
lysed to identify what percentage of the countries
reported having AMR indicators in place. The other
most commonly noted AMR structures were also col-
lated and included, to give a deeper insight (Table 2). Al-
though there were questions regarding animal Infection
Prevention and Control (IPC), they were a new addition
to the JEE technical questions, from the Second Edition
[24] and as a result few countries provided a written re-
sponse to them, so it was therefore not included as an
indicator in this report. These indicator scores were
weighted into African regions (15 West, 7 Central, 17
East and 5 Southern African countries, as defined by the
United Nations) to highlight any particular patterns of
AMR preparedness strengths. The guidelines for how
scores are ascribed are outlined in the JEE Tool [24, 26].
Results
The mean SSA ‘AMR’ score was 1.42 (range 1.00–3.50),
ranking it 17th among the 19 sub-areas when all sub-
area mean scores for SSA were calculated (Table 3). This
was 53% lower than the overall mean JEE SSA prepared-
ness score of 3.05 (range 2.31–4.17). Figure 3 shows the
mean AMR score for each country by colour category,
as described in the JEE tool document. When compared,
there was significance difference between the sub-areas
(p = < 0.0001).
When the mean of each AMR category was calculated
there was a significant difference between the mean SSA
category scores (p = 0.0207). ‘IPC’ had the highest mean
score of 1.70 (range 1.00–5.00), while ‘Antimicrobial
Stewardship’ had the lowest mean score of 1.23 (range
1.00–3.00).
Table 4 lists the mean SSA country score for each cat-
egory and what percentage of countries scored 1–5.
When countries were weighted by region, East Africa
had the highest score when averaged across all AMR
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categories. Table 5 shows the mean regional scores for
each AMR category, as well as whether there were sig-
nificant differences between regions within each cat-
egory. Only East Africa scored a category mean of > 2, in
the ‘IPC’ category.
Each AMR category identified preparedness indicators,
but responses to each of the technical questions were
not uniform. National Action Plans for AMR are in
place for 25% of SSA countries. 32% stated they con-
ducted routine clinical pathogen AMR surveillance, as
opposed to one country (2%) stating that they conducted
routine veterinary pathogen AMR surveillance. Many
countries reported that they conducted ad hoc, or
research-based surveillance studies, but did not have a
Fig. 1 Maps showing the status of JEE completion of SSA countries. Black indicates that a country has not completed a JEE (at the time of
writing Angola, Cape Verde, Djibouti, Equatorial Guinea, Somalia and Sudan are either in the process of completing or have not yet undertaken a
JEE report), blue indicates a country that has a completed JEE. Countries in grey denote Northern African countries not included in this review
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Fig. 2 Explanation of how JEE data was analysed in this study. The mean of country AMR category scores was used as a ‘mean country AMR
score’ (indicated by the blue solid line) and compared to other SSA countries (indicated by the black dotted line). The mean of all the ‘Mean
country AMR scores’ was used as a ‘Mean SSA AMR score’ (indicated by the blue solid line) and then compared to other mean SSA sub-areas, e.g.
immunisation (indicated by the black dotted line). ‘Mean country AMR scores were also weighted into regions (West, Central, East and Southern
Africa) and compared (indicated by the black dotted line)
Table 2 AMR preparedness categories and the indicators explored in this paper. Indicators are either taken directly from the scoring
table (see the JEE tool [24, 26]) or they were from technical question answers from the technical questions
Category Indicator Source
Effective multisectoral coordination on AMR and the national
action plan (in this paper referred to as ‘National Action Plan’)
Is there a National Action Plan in place? Scoring table within
the JEE tools document
AMR surveillance
(in this paper referred to as ‘AMR surveillance)
Are human pathogen samples routinely tested for AMR? Technical questions
Are animal pathogen samples routinely tested for AMR? Technical questions
Is there a national human pathogen surveillance system in
place?
Scoring table within
the JEE tools document
Is there a national animal pathogen surveillance system in
place?
Scoring table within
the JEE tools document
Is there a national AMR reference laboratory? Technical questions
Infection Prevention and Control
(in this paper referred to as ‘IPC’)
Are there sufficient Water, Sanitation and Hygiene (WASH)
programmes in place across all healthcare facilities in the
country?
Scoring table within
the JEE tools document
Are there national training programmes (e.g. at higher
education institutes on IPC?
Technical questions
Optimise use of antimicrobial medicines in
human and animal health and agriculture
(in this paper referred to as ‘Antimicrobial stewardship’)
Are there guidelines in place for the use of antimicrobials? Scoring table within
the JEE tools document
Is there legislation in place for the distribution and use of
clinical antimicrobials?
Technical questions
Is there legislation in place for the distribution and use of
veterinary antimicrobials?
Technical questions
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national programme in place. 66% of countries routinely
collected and tested human pathogen samples for AMR
and 25% collected and tested animal pathogens for
AMR. The majority (59%) of SSA countries reported
sending their AMR samples to a dedicated AMR Na-
tional Reference Laboratory.
‘Infection Prevention and Control’ had the highest mean
SSA category score and 25% of countries reported that
they conduct training on AMR in an IPC capacity. Most
countries (95%) did not have fully functional WASH or
environmental health standards in place across all health-
care facilities. This category also had technical questions
relating to animal IPC, although only six countries (Cen-
tral African Republic, Chad, Ethiopia, Malawi, São Tomé
and Príncipe and Zanzibar) specifically referred to animal
IPC, and only Central African Republic mentioned animal
IPC as a ‘strength’ rather than a ‘challenge’. The majority
of answers from the technical questions centred around
health care-associated infections.
For ‘Antimicrobial Stewardship’, 32% of countries
stated that they had national guidelines for the appropri-
ate distribution and use of antimicrobials. Prescription-
only rules for the clinical use of antimicrobials were re-
ported in 43% of countries, but the percentage of coun-
tries reporting legislation of antimicrobials for veterinary
use was lower (32%). Most countries who reported
having legislation in place stated that despite these regu-
lations, issues with counterfeit drugs and the lack of en-
forcement was a problem. Some countries are in the
process of making antimicrobials prescription-only,
whilst others report extensive concerns over the uncon-
trolled use of unregulated and counterfeit antimicrobials.
This is especially true for the veterinary sector, with an-
timicrobials often reported to be sold in village shops
manned by store workers untrained in antimicrobial use.
Antimicrobials were often reported to be used as a sup-
plement to enhance growth and prevent diseases in
poultry farms and beef and dairy production, although a
few countries reported that antimicrobial use for animal
growth promotion had been banned.
When assessing the AMR preparedness indicators by
region, East Africa had the greatest number of countries
with a National Action Plan (41%), national human and
animal pathogen AMR surveillance programmes (65
and 47%, respectively) and routine animal pathogen
AMR testing (47%) (Table 6). Southern Africa had the
highest percentage of countries reporting routine hu-
man pathogen AMR testing, whilst Central Africa had
the greatest number of countries with a national AMR
reference laboratory (86%). Southern Africa scored high-
est of the regions for IPC training (60%), but East Africa
was the only region with countries reporting to have
Table 3 Mean sub-Saharan African JEE scores when weighted by sub-area
JEE Area JEE Sub-area Mean SSA score Ranking
Prevent National legislation, policy and financing 1.45 15
IHR coordination, communication and advocacy 1.91 10
Antimicrobial resistance 1.42 17
Zoonotic diseases 2.35 5
Food safety 1.91 10
Biosafety and security 1.63 12
Immunization 3.38 1
Detect National laboratory system 2.44 4
Real time surveillance 2.90 2
Reporting 2.26 7
Workforce development 2.50 3
Respond Emergency preparedness 1.42 18
Emergency response operations 1.92 9
Linking public health and security authorities 1.98 8
Medical countermeasures and personnel deployment 1.33 19
Risk communication 2.30 6
IHR other Points of entry 1.43 16
Chemical events 1.57 13
Radiation emergencies 1.51 14
The mean of each countries’ scores for all questions in each sub-area was calculated, then the mean of all of the country means was calculated. The AMR sub-area
is highlighted in bold. The rankings were calculated based on the mean score for each category for the 44 SSA countries.
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functional WASH facilities in line with national stan-
dards (12%). Southern Africa also reported the highest
percentage of countries with antimicrobial legislation
for clinical and veterinary use in place and 40% of
Southern African countries had antimicrobial usage
guidelines.
Discussion
JEEs are powerful tools for identifying strengths and
weaknesses in a country’s ability to deal with global
health risks, as they present a defined set of indicators
against which all countries can be compared. By com-
paring SSA country JEE scores and identifying where
Fig. 3 Map showing SSA country mean AMR JEE scores by colour category. Black denotes a country that has not completed a JEE and grey
denotes North African countries not included in this review. Red indicates a JEE score of 1 (‘no capacity’). Yellow indicates a score of 2 or 3
(‘limited capacity’ or ‘developed capacity’) and green indicates a score of 4 or 5 (‘demonstrated capacity’ or ‘sustainable capacity’)
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AMR sits in comparison to other JEE categories, we have
shown that, whilst much work needs to be done to bring
AMR in line with other areas, such as immunisation,
there are countries and regions who have successfully
implemented AMR control initiatives. The low mean
SSA AMR preparedness score compared to the SSA JEE
preparedness score suggests that until now AMR has
not been a priority for most SSA countries, compared to
the other sub-areas. The fact that the majority of coun-
tries lack an AMR National Action Plan suggests that
they may have been lacking a focussed and coordinated
response, although many stated that they are beginning
to prepare and implement them, which is a positive step
forward in the fight against AMR. With the lowest mean
AMR category score, ‘Antimicrobial Stewardship’ needs
the greatest JEE score improvement to align it with the
other AMR categories. Focussing attention on anti-
microbial stewardship will improve countries’ AMR pre-
paredness scores and bring AMR in line with the other
sub-areas, such as immunisation. Whilst it could be ar-
gued that AMR may not necessarily be a problem on the
same scale as other public health issues, without national
surveillance in place it is very difficult to tell the true ex-
tent of the problem.
The technical questions provide a deeper insight into
the facilities in place, and yet to be achieved for each
country. A constraint of this study was that the analysed
indicators depended on the depth of the written
response of each country, and whether the indicator was
mentioned as being present or not. Whilst most coun-
tries mentioned whether they had, or were in the
process of writing a National Action Plan for instance,
fewer countries mentioned whether they conducted IPC
training, and in general, veterinary indicators had fewer
and less detailed responses. The lack of veterinary re-
sponses to these technical questions suggests that veter-
inary professionals might not yet be fully integrated into
many countries’ public health response teams, however
the creation of a multisectoral approach is a prominent
part of the WHO’s Global action plan for AMR, which
should address this [27].
There needs to be wilful political commitment to ad-
dress AMR, including designated funding and the imple-
mentation of a fully multidisciplinary National Action
Plan if countries are to make maximum use of their clin-
ical and veterinary facilities. With the majority of coun-
tries reporting ‘no capacity’ for ‘AMR Surveillance’,
capacity needs to be built nationally and regionally to
obtain the necessary surveillance levels for key human
and animal pathogen AMRs, for example those identi-
fied in the GLASS [28]. Many JEEs report that although
countries don’t currently undertake national AMR test-
ing, some do have significant laboratory capacities
already in place, which could be quickly utilised in the
future. This capacity needs to include susceptibility as-
says, training of diagnostic staff in testing methods and
Table 4 Percentage of countries who scored 1–5 for each category
Score National Action Plan AMR Surveillance Infection Prevention and Control Antimicrobial Stewardship
1 73% 77% 57% 82%
2 14% 16% 20% 14%
3 11% 5% 20% 5%
4 2% 2% 0% 0%
5 0% 0% 2% 0%
Mean score 1.43 1.32 1.70 1.23
P value p = 0.0207
A score of 1 indicates no capacity, 2 indicates limited capacity, 3 indicates developed capacity, 4 indicates demonstrated capacity and 5 indicates sustainable
capacity. The majority of countries scored 1 in each AMR category.
Table 5 SSA mean AMR category scores by region
African region and total
countries within it
National Action
Plan
AMR
Surveillance
Infection Prevention
and Control
Antimicrobial
Stewardship
Regional AMR
mean
Regional overall JEE
mean
West 15 1.20 1.07 1.53 1.07 1.22 2.15
Central 7 1.29 1.00 1.14 1.00 1.11 2.00
East 17 1.71 1.65 2.18 1.47 1.75 2.38
Southern 5 1.40 1.40 1.40 1.20 1.35 2.40
p value p = 0.3168 p = 0.0407 p = 0.0493 p = 0.0866 p = 0.0207 p = 0.0113
Total countries within each region are those with JEE scores. Countries without JEE scores were not included in this table.
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the implementation of quality control protocols [4, 5,
29]. To ensure this is sustainable and attainable, a step-
wise approach should be used [30].
Some countries reported doing small-scale studies,
thus some data on AMR are being collected, but this is
often not translated into country-wide AMR surveillance
with government-level reporting. The increasing deploy-
ment of app-based digital pathogen and case reporting,
such as the surveillance and outbreak response manage-
ment system (SORMAS) should make surveillance and
reporting easier [31]. A systematic approach needs to be
developed through routine data collection and enrol-
ment of more surveillance sites for increased capacity. In
most countries, there is a need to strengthen the One
Health aspect of surveillance and incorporate veterinary
and environmental monitoring into any existing clinical
programmes, although recent publications suggest that
this is now at least a consideration for some countries
[21, 29]. Enrolling in the WHO GLASS can help coun-
tries identify priority needs.
Although this study has shown that ‘Infection Preven-
tion and Control’ had the highest SSA average score out
of the four AMR categories, it still has room for im-
provement. As part of the National Action Plan, a na-
tional IPC programme for human health, animal health
and food production (including policies, guidelines and
dissemination strategies) must be implemented, so that a
One Health system for integrated assessments of the
safety and functionality of facilities for public health
emergencies is in place. Steps are being made, as AMR
is mentioned in the IPC guidelines published by WHO
AFRO [32]. Although the vast majority of countries re-
ported having insufficient WASH or IPC programmes in
their healthcare facilities, most did report having some
level of IPC in most sites, especially in larger clinical
sites. Functional IPC committees must be set up to
cover all human and animal health facilities to ensure
the training and awareness of health care professionals,
whilst also ensuring that disinfectants, personnel pro-
tective equipment and suitable waste disposal systems
are readily available so staff can carry out IPC success-
fully [33]. If good practice in the larger facilities can be
reproduced in local, veterinary and environmental facil-
ities, this should quickly boost the IPC programmes cat-
egory score for SSA countries.
‘Antimicrobial Stewardship’ scored the lowest of all
the AMR categories, suggesting that by focussing on
this, real gains can be made in the fight against AMR.
Whilst the introduction of antimicrobial stewardship
has proved successful in some countries, and can be
used as a template for others [34, 35], this study has
shown that most countries still need to create and im-
plement national guidelines on the appropriate distri-
bution and use of antimicrobials in a One Health
capacity to limit the risk of resistance transmission
[14]. Increased national awareness of AMR and the
legislated use of antimicrobials is required, and profes-
sional bodies should be instigated to regulate and edu-
cate the pharmaceutical practices of both human and
animal healthcare professionals. This needs to be ex-
tended to antimicrobial retailers and field workers in
communities, who are often at the forefront of anti-
microbial dispensing. Updating a country’s essential
drugs list and the laws regulating access to antimicro-
bials in clinical, veterinary and agricultural settings will
help to ensure that legislation is correctly enforced. To
aid this decision making, more research is needed to
better inform treatment guidelines and importantly, to
identify alternatives to antimicrobials as animal growth
promoters.
Table 6 The percentage of countries, overall and broken down by region, who stated that they had AMR indicators present in their
technical question answers
SSA region, including number of countries
All SSA countries West Central East Southern
(44 countries) (15 countries) (7 countries) (17 countries) (5 countries)AMR indicators
National Action Plan in place 11 (25%) 2 (13%) 1 (14%) 7 (41%) 1 (20%)
Human pathogen AMR surveillance 17 (39%) 3 (20%) 3 (43%) 9 (53%) 2 (40%)
Animal pathogen AMR surveillance 1 (2%) 0 (0%) 0 (0%) 1 (6%) 0 (0%)
Human pathogen AMR testing 29 (66%) 11 (73%) 3 (43%) 11 (65%) 4 (80%)
Animal pathogen AMR testing 11 (25%) 2 (13%) 0 (0%) 8 (47%) 1 (20%)
National AMR laboratory 27 (61%) 7 (47%) 6 (86%) 10 (59%) 4 (80%)
IPC prevention and control training 11 (25%) 3 (20%) 2 (29%) 3 (18%) 3 (60%)
Sufficient WASH programmes in place 2 (5%) 0 (0%) 0 (0%) 2 (12%) 0 (0%)
Drug stewardship framework 11 (25%) 3 (20%) 1 (14%) 5 (29%) 2 (40%)
Clinical antimicrobial legislation 19 (43%) 5 (33%) 2 (29%) 7 (41%) 5 (100%)
Veterinary antimicrobial legislation 14 (32%) 5 (33%) 2 (29%) 3 (18%) 4 (80%)
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With the two highest regional mean AMR scores,
AMR preparedness lessons can be learned from both
East and Southern Africa. East Africa, with the highest
percentage of countries with multisectoral National Ac-
tion Plans, collection of animal pathogen AMR data and
both human and animal pathogen AMR surveillance, ap-
pears to have embraced the One Health approach and
the importance of surveillance. Southern Africa has the
highest percentage of countries with antimicrobial stew-
ardship guidelines in place, as well as the highest per-
centage of countries with human and animal
antimicrobial legislation in place.
Conclusions
This study has compared the AMR section of the JEE re-
ports for SSA to compare countries and regions and
identify key strengths that can be adapted and utilised
across the continent. The key points identified in this
study suggest that SSA countries need to fully involve
clinical, veterinary and environmental departments if
they are to build a robust One Health AMR prepared-
ness response. To do this, they must share their experi-
ences and adapt the successful programmes from
countries with strong AMR responses to suit their own
unique needs to ensure a standardised and coordinated
assault on AMR.
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